Torthaí cuardaigh - Constantine Alifrangis

  • 1 - 8 toradh as 8 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis

    EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis de réir Constantine Alifrangis, Roshan Agarwal, Delia Short, Rosemary A. Fisher, Neil J. Sebire, Richard J. Harvey, Philip Savage, Michael J. Seckl

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

    Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up de réir A. Muneer, Marco Bandini, Éva Compérat, Gert De Meerleer, Karim Fizazi, Jourik A. Gietema, Silke Gillessen, Alex Kirkham, Vijay Sangar, Constantine Alifrangis, Tom Powles

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model

    BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model de réir Daniele Perna, Florian A. Karreth, Alistair G. Rust, Pedro A. Pérez–Mancera, Mamunur Rashid, Francesco Iorio, Constantine Alifrangis, Mark J. Arends, Marcus Bosenberg, Gideon Bollag, David A. Tuveson, David J. Adams

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    <i><scp>BRAF</scp></i>/<i><scp>NRAS</scp></i> wild‐type melanoma, <scp>NF</scp>1 status and sensitivity to trametinib

    <i><scp>BRAF</scp></i>/<i><scp>NRAS</scp></i> wild‐type melanoma, <scp>NF</scp>1 status and sensitivity to trametinib de réir Marco Ranzani, Constantine Alifrangis, Daniele Perna, Ken Dutton‐Regester, Antonia L. Pritchard, Kim Wong, Mamunur Rashid, Carla Daniela Robles‐Espinoza, Nicholas K. Hayward, Ultan McDermott, Mathew J. Garnett, David J. Adams

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Inactivating CUX1 mutations promote tumorigenesis

    Inactivating CUX1 mutations promote tumorigenesis de réir Chi Chun Wong, Sancha Martin, Alistair G. Rust, Mamunur Rashid, Constantine Alifrangis, Ludmil B. Alexandrov, Jessamy Tiffen, Christina Kober, Anthony R. Green, Charles Massie, Jyoti Nangalia, Stella Lempidaki, Hartmut Döhner, Konstanze Döhner, Sarah J. Bray, Ultan McDermott, Elli Papaemmanuil, Peter J. Campbell, David J. Adams

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

    The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer de réir Caitlin R. Davies, Tianyu Guo, Edwina Burke, Elzbieta Stankiewicz, Lei Xu, Xueying Mao, Glenda Scandura, Prabhakar Rajan, Karen Tipples, Constantine Alifrangis, Akhila Wimalasingham, Myria Galazi, Shanthini M. Crusz, Thomas Powles, Alistair Grey, R.T.D. Oliver, Sakunthala C. Kudahetti, Greg Shaw, Daniel M. Berney, Jonathan Shamash, Yong‐Jie Lu

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing

    The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing de réir Tianyu Guo, Yang Wang, Jing Jia, Xueying Mao, Elzbieta Stankiewicz, Glenda Scandura, Edwina Burke, Lei Xu, Jacek Marzec, Caitlin R. Davies, Jiaying Lu, Prabhakar Rajan, Alistair Grey, Karen Tipples, John Hines, Sakunthala C. Kudahetti, R.T.D. Oliver, Thomas Powles, Constantine Alifrangis, Manish Kohli, Greg Shaw, Wen Wang, Ninghan Feng, Jonathan Shamash, Daniel M. Berney, Liang Wang, Yong‐Jie Lu

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    ctDNA monitoring using patient-specific sequencing and integration of variant reads

    ctDNA monitoring using patient-specific sequencing and integration of variant reads de réir Jonathan C. M. Wan, Katrin Heider, Davina Gale, Suzanne Murphy, Eyal Fisher, Florent Moulière, Andrea Ruiz-Valdepeñas, Ángela Santonja, James Morris, Dineika Chandrananda, Andrea Marshall, Andrew B. Gill, Pui Ying Chan, Emily Barker, Gemma Young, Wendy N. Cooper, Irena Hudecova, Francesco Marass, Richard Mair, Kevin M. Brindle, Grant D. Stewart, Jean Abraham, Carlos Caldas, Doris M. Rassl, Robert C. Rintoul, Constantine Alifrangis, Mark R. Middleton, Ferdia A. Gallagher, Christine Parkinson, Amer Durrani, Ultan McDermott, Christopher G. Smith, Charles Massie, Pippa Corrie, Nitzan Rosenfeld

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: